The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sunitinib plus paclitaxel in patients with advanced esophageal cancer: A phase II study from the Hoosier Oncology Group.
J. M. Schmitt
No relevant relationships to disclose
S. R. Sommers
No relevant relationships to disclose
W. B. Fisher
No relevant relationships to disclose
R. H. Ansari
No relevant relationships to disclose
E. L. Robin
No relevant relationships to disclose
K. Koneru
No relevant relationships to disclose
J. W. McClean
No relevant relationships to disclose
Z. Liu
No relevant relationships to disclose
N. H. Hanna
No relevant relationships to disclose